Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant interleukin-1-beta
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Phase II Study of 131I-Labeled MOAB CC49 plus IL-1B in Patients with Colorectal Cancer (Summary Last Modified 06/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAC-2110, NCI-T91-0203C, T91-0203
Phase II Study of IL-1B in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 08/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WSU-C-98591, NCI-T91-0272D, T91-0272
Phase I Study of IL-1B/CBDCA/VP-16 in Patients with Metastatic Cancer (Summary Last Modified 08/92)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-8940
Phase IB Study of Interleukin-1-beta in Patients with Advanced Solid Tumors (Summary Last Modified 06/97)
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8811A, NCI-90-C-62A, NCI-T89-0185N, T89-0185
Phase I Study of IL-1B/IL-2 in Patients with Metastatic Kidney Cancer, Colorectal Cancer, or Malignant Melanoma (Summary Last Modified 02/92)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: OSU-91HO154, NCI-B91-0021, B91-0021
Phase I Pilot Study of IL-1B with and without CBDCA/CTX in Patients with Advanced Cancer (Summary Last Modified 01/94)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-900302, NCI-T91-0157C, T91-0157
Start Over